<?xml version="1.0" encoding="UTF-8"?><mods xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.loc.gov/mods/v3" version="3.3" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-3.xsd" ID="id-2016-21337">
    <name type="corporate">
        <namePart>United States Government Publishing Office</namePart>
        <role>
            <roleTerm authority="marcrelator" type="text">publisher</roleTerm>
            <roleTerm authority="marcrelator" type="code">pbl</roleTerm>
        </role>
        <role>
            <roleTerm authority="marcrelator" type="text">distributor</roleTerm>
            <roleTerm authority="marcrelator" type="code">dst</roleTerm>
        </role>
    </name>
    <name type="corporate">
        <namePart>United States</namePart>
        <namePart>National Archives and Records Administration</namePart>
        <namePart>Office of the Federal Register</namePart>
        <role>
            <roleTerm authority="marcrelator" type="text">author</roleTerm>
            <roleTerm authority="marcrelator" type="code">aut</roleTerm>
        </role>
        <description>Government Organization</description>
    </name>
    <typeOfResource>text</typeOfResource>
    <genre authority="marcgt">government publication</genre>
    <language>
        <languageTerm type="code" authority="iso639-2b">eng</languageTerm>
    </language>
    <extension>
        <collectionCode>FR</collectionCode>
        <category>Regulatory Information</category>
        <waisDatabaseName>2016_register</waisDatabaseName>
        <branch>executive</branch>
        <dateIngested>2018-02-09</dateIngested>
    </extension>
    <genre authority="marcgt">article</genre>
    <titleInfo>
        <title>Safety and Effectiveness of Consumer Antiseptics; Topical Antimicrobial Drug Products for Over-the-Counter Human Use</title>
        <partName>Rules and Regulations</partName>
    </titleInfo>
    <relatedItem type="otherFormat" xlink:href="https://www.govinfo.gov/content/pkg/FR-2016-09-06/html/2016-21337.htm">
        <identifier type="FDsys Unique ID">D09002ee1c7f4314c</identifier>
    </relatedItem>
    <relatedItem type="otherFormat" xlink:href="https://www.govinfo.gov/content/pkg/FR-2016-09-06/pdf/2016-21337.pdf">
        <identifier type="FDsys Unique ID">D09002ee1c7f431bc</identifier>
    </relatedItem>
    <name type="corporate">
        <namePart>United States</namePart>
        <namePart>Department of Health and Human Services</namePart>
        <role>
            <roleTerm authority="marcrelator" type="text">originator</roleTerm>
            <roleTerm authority="marcrelator" type="code">org</roleTerm>
        </role>
        <description>United States Government Agency or Subagency</description>
    </name>
    <name type="corporate">
        <namePart>United States</namePart>
        <namePart>Food and Drug Administration</namePart>
        <role>
            <roleTerm authority="marcrelator" type="text">originator</roleTerm>
            <roleTerm authority="marcrelator" type="code">org</roleTerm>
        </role>
        <description>United States Government Agency or Subagency</description>
    </name>
    <abstract>The Food and Drug Administration (FDA, we, or the Agency) is issuing this final rule establishing that certain active ingredients used in over-the-counter (OTC) consumer antiseptic products intended for use with water (referred to throughout this document as consumer antiseptic washes) are not generally recognized as safe and effective (GRAS/GRAE) and are misbranded. FDA is issuing this final rule after considering the recommendations of the Nonprescription Drugs Advisory Committee (NDAC); public comments on the Agency's notices of proposed rulemaking; and all data and information on OTC consumer antiseptic wash products that have come to the Agency's attention. This final rule amends the 1994 tentative final monograph (TFM) for OTC antiseptic drug products that published in the Federal Register of June 17, 1994 (the 1994 TFM). The final rule is part of the ongoing review of OTC drug products conducted by FDA.</abstract>
    <identifier type="FR citation">81 FR 61106</identifier>
    <identifier type="uri">https://www.govinfo.gov/app/details/FR-2016-09-06/2016-21337</identifier>
    <identifier type="FR Doc No.">2016-21337</identifier>
    <identifier type="former granule identifier">fr06se16-5</identifier>
    <identifier type="Regulation ID Number">RIN 0910-AF69</identifier>
    <identifier type="billing code">4164-01-P</identifier>
    <identifier type="department code">Docket No. FDA-1975-N-0012</identifier>
    <identifier type="department code">Formerly Part of Docket No. 1975N-0183H</identifier>
    <location>
        <url displayLabel="Content Detail" access="object in context">https://www.govinfo.gov/app/details/FR-2016-09-06/2016-21337</url>
        <url access="raw object" displayLabel="HTML rendition">https://www.govinfo.gov/content/pkg/FR-2016-09-06/html/2016-21337.htm</url>
        <url access="raw object" displayLabel="PDF rendition">https://www.govinfo.gov/content/pkg/FR-2016-09-06/pdf/2016-21337.pdf</url>
    </location>
    <subject>
        <topic>Administrative Practice and Procedure</topic>
        <topic>Drugs</topic>
        <topic>Labeling</topic>
        <topic>Medical Devices</topic>
        <topic>Reporting and Recordkeeping Requirements</topic>
    </subject>
    <physicalDescription>
        <extent>25 p.</extent>
    </physicalDescription>
    <part type="Rules and Regulations">
        <extent unit="pages">
            <start>61106</start>
            <end>61130</end>
        </extent>
    </part>
    <identifier type="preferred citation">81 FR 61106</identifier>
    <relatedItem type="isReferencedBy">
        <titleInfo>
            <title>Code of Federal Regulations</title>
            <partNumber>Title 21 Part 310</partNumber>
        </titleInfo>
        <identifier type="CFR citation">21 CFR Part  310</identifier>
    </relatedItem>
    <relatedItem type="isReferencedBy">
        <titleInfo>
            <title>Regulation Identification Number 0910-AF69</title>
        </titleInfo>
        <identifier type="regulation ID number">RIN 0910-AF69</identifier>
    </relatedItem>
    <extension>
        <searchTitle>Safety and Effectiveness of Consumer Antiseptics; Topical Antimicrobial Drug Products for Over-the-Counter Human Use; Federal Register Vol. 81, Issue </searchTitle>
        <granuleClass>RULE</granuleClass>
        <accessId>2016-21337</accessId>
        <agency order="1">DEPARTMENT OF HEALTH AND HUMAN SERVICES</agency>
        <agency order="2">Food and Drug Administration</agency>
        <effectiveDate>2017-09-06</effectiveDate>
        <departmentDoc>Docket No. FDA-1975-N-0012</departmentDoc>
        <departmentDoc>Formerly Part of Docket No. 1975N-0183H</departmentDoc>
        <rin number="0910-AF69"/>
        <billingCode>4164-01-P</billingCode>
        <frDocNumber>2016-21337</frDocNumber>
        <action>Final rule.</action>
        <summary>The Food and Drug Administration (FDA, we, or the Agency) is issuing this final rule establishing that certain active ingredients used in over-the-counter (OTC) consumer antiseptic products intended for use with water (referred to throughout this document as consumer antiseptic washes) are not generally recognized as safe and effective (GRAS/GRAE) and are misbranded. FDA is issuing this final rule after considering the recommendations of the Nonprescription Drugs Advisory Committee (NDAC); public comments on the Agency's notices of proposed rulemaking; and all data and information on OTC consumer antiseptic wash products that have come to the Agency's attention. This final rule amends the 1994 tentative final monograph (TFM) for OTC antiseptic drug products that published in the Federal Register of June 17, 1994 (the 1994 TFM). The final rule is part of the ongoing review of OTC drug products conducted by FDA.</summary>
        <dates>This rule is effective September 6, 2017.</dates>
        <contact>Pranvera Ikonomi, Center for Drug Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 22, Rm. 5418, Silver Spring, MD 20993-0002, 240- 402-0272.</contact>
        <cfr title="21">
                                    
            <part number="310"/>
                                    
            <subject>Administrative Practice and Procedure</subject>
                                    
            <subject>Drugs</subject>
                                    
            <subject>Labeling</subject>
                                    
            <subject>Medical Devices</subject>
                                    
            <subject>Reporting and Recordkeeping Requirements</subject>
                                
        </cfr>
        <tocSubject1>Safety and Effectiveness of Consumer Antiseptics:</tocSubject1>
        <tocDoc>Topical Antimicrobial Drug Products for Over-the-Counter Human Use
, </tocDoc>
        <urlRef>http://aac.asm.org/content/48/8/2973.full.pdf+html</urlRef>
        <urlRef>http://aac.asm.org/content/58/11/6424.full.pdf+html</urlRef>
        <urlRef>http://aac.asm.org/content/59/6/3413.full</urlRef>
        <urlRef>http://annals.org/article.aspx?articleid=694897</urlRef>
        <urlRef>http://annals.org/article.aspx?articleid=717252</urlRef>
        <urlRef>http://bmcgenomics.biomedcentral.com/articles/10.1186/s12864-015-1544-y</urlRef>
        <urlRef>http://citeseerx.ist.psu.edu/viewdoc/download?doi=10.1.1.492.3167&amp;rep=rep1&amp;type=pdf</urlRef>
        <urlRef>http://ec.europa.eu/health/archive/ph_risk/committees/04_sccp/docs/sccp_o_166.pdf</urlRef>
        <urlRef>http://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_054.pdf</urlRef>
        <urlRef>http://ec.europa.eu/health/scientific_committees/consumer_safety/index_en.htm</urlRef>
        <urlRef>http://echa.europa.eu/web/guest/information-on-chemicals/registered-substances</urlRef>
        <urlRef>http://jac.oxfordjournals.org/content/67/12/2837.full.pdf+html</urlRef>
        <urlRef>http://jcp.bmj.com/content/29/8/752.long</urlRef>
        <urlRef>http://journals.plos.org/plosone/article/authors?id=10.1371%2Fjournal.pone.0078310</urlRef>
        <urlRef>http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0062197</urlRef>
        <urlRef>http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0086669</urlRef>
        <urlRef>http://link.springer.com/article/10.1038/sj.jim.7000320#page-1</urlRef>
        <urlRef>http://ntp.niehs.nih.gov/ntp/about_ntp/bsc/2014/june/triclocarban_concept_508.pdf</urlRef>
        <urlRef>http://ntp.niehs.nih.gov/results/pubs/longterm/reports/longterm/tr300399/abstracts/tr330/index.html</urlRef>
        <urlRef>http://online.liebertpub.com/doi/abs/10.1089/mdr.2012.0225</urlRef>
        <urlRef>http://pediatrics.aappublications.org/content/127/Supplement_1/S31</urlRef>
        <urlRef>http://pediatrics.aappublications.org/content/pediatrics/127/Supplement_1/S31.full.pdf</urlRef>
        <urlRef>http://www.aciscience.org/docs/Triclocarban_HPV_Robust_Study_Summaries.pdf</urlRef>
        <urlRef>http://www.ajicjournal.org/article/0196-6553</urlRef>
        <urlRef>http://www.bioinfopublication.org/files/articles/3_2_4_IJMR.pdf</urlRef>
        <urlRef>http://www.cdc.gov/mmwr/preview/mmwrhtml/00001358.htm</urlRef>
        <urlRef>http://www.fda.gov/AboutFDA/ReportsManualsForms/Reports/EconomicAnalyses/default.htm</urlRef>
        <urlRef>http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/NonprescriptionDrugsAdvisoryCommittee/UCM421121.pdf</urlRef>
        <urlRef>http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm074916.pdf</urlRef>
        <urlRef>http://www.fda.gov/Drugs/DevelopmentApprovalProcess/DevelopmentResources/Over-the-CounterOTCDrugs/StatusofOTCRulemakings/ucm070821.htm</urlRef>
        <urlRef>http://www.fda.gov/ohrms/dockets/ac/05/transcripts/2005-4098T1.htm</urlRef>
        <urlRef>http://www.fda.gov/ohrms/dockets/ac/05/transcripts/2005-4184T1.pdf</urlRef>
        <urlRef>http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Safety/S1B/Step4/S1B_Guideline.pdf</urlRef>
        <urlRef>http://www.jstor.org/stable/4456469?seq=1#page_scan_tab_contents</urlRef>
        <urlRef>http://www.karger.com/Article/PDF/246028</urlRef>
        <urlRef>http://www.ncbi.nlm.nih.gov/pubmed/12011534</urlRef>
        <urlRef>http://www.ncbi.nlm.nih.gov/pubmed/12969278</urlRef>
        <urlRef>http://www.ncbi.nlm.nih.gov/pubmed/14529640</urlRef>
        <urlRef>http://www.ncbi.nlm.nih.gov/pubmed/14678175</urlRef>
        <urlRef>http://www.ncbi.nlm.nih.gov/pubmed/14715734</urlRef>
        <urlRef>http://www.ncbi.nlm.nih.gov/pubmed/1656744</urlRef>
        <urlRef>http://www.ncbi.nlm.nih.gov/pubmed/18593388</urlRef>
        <urlRef>http://www.ncbi.nlm.nih.gov/pubmed/19273638</urlRef>
        <urlRef>http://www.ncbi.nlm.nih.gov/pubmed/20541914</urlRef>
        <urlRef>http://www.ncbi.nlm.nih.gov/pubmed/22752336</urlRef>
        <urlRef>http://www.ncbi.nlm.nih.gov/pubmed/23290239</urlRef>
        <urlRef>http://www.ncbi.nlm.nih.gov/pubmed/23566146</urlRef>
        <urlRef>http://www.ncbi.nlm.nih.gov/pubmed/25059442</urlRef>
        <urlRef>http://www.ncbi.nlm.nih.gov/pubmed/712607</urlRef>
        <urlRef>http://www.ncbi.nlm.nih.gov/pubmed/8148192</urlRef>
        <urlRef>http://www.ncbi.nlm.nih.gov/pubmed/9403268</urlRef>
        <urlRef>http://www.ncbi.nlm.nih.gov/pubmed/?term=Absorption+and+metabolism+of+triclosan+after+application+to+the+skin+of+B6C3F1+mice</urlRef>
        <urlRef>http://www.ncbi.nlm.nih.gov/pubmed/?term=Adapted+tolerance+to+benzalkonium+chloride+in+Escherichia+coli+K-12+studied+by+transcriptome+and+proteome+analyse</urlRef>
        <urlRef>http://www.ncbi.nlm.nih.gov/pubmed/?term=Carson+RT%2C+Larson+E%2C+Levy+SB%2C+Marshall+BM%2C+Aiello+AE</urlRef>
        <urlRef>http://www.ncbi.nlm.nih.gov/pubmed/?term=Coelho+JR%2C+Carri%C3%A7o+JA%2C+Knight+D%2C+Mart%C3%ADnez+JL%2C+Morrissey+I%2C+Oggioni+MR%2C+Freitas+AT</urlRef>
        <urlRef>http://www.ncbi.nlm.nih.gov/pubmed/?term=Evaluation+of+chlorhexidine+and+povidone+iodine+activity+against+methicillin-resistant+Staphylococcus+aureus+and+vancomycin-resistant+Enterococcus+faecalis+using+a+surface+test</urlRef>
        <urlRef>http://www.ncbi.nlm.nih.gov/pubmed/?term=FDA-iRISK-a+comparative+risk+assessment+system+for+evaluating+and+ranking+food-hazard+pairs%3A+case+studies+on+microbial+hazards</urlRef>
        <urlRef>http://www.ncbi.nlm.nih.gov/pubmed/?term=Involvement+of+efflux+mechanisms+in+biocide+resistance+of+Campylobacter+jejuni+and+Campylobacter+coli8</urlRef>
        <urlRef>http://www.ncbi.nlm.nih.gov/pubmed/?term=Joynson+JA%2C+Forbes+B%2C+Lambert+RJ</urlRef>
        <urlRef>http://www.ncbi.nlm.nih.gov/pubmed/?term=Quantitative+microbial+risk+assessment+of+antibacterial+hand+hygiene+products+on+risk+of+shigellosis</urlRef>
        <urlRef>http://www.ncbi.nlm.nih.gov/pubmed/?term=Short-term+in+vivo+exposure+to+the+water+contaminant+triclosan%3A+Evidence+for+disruption+of+thyroxine</urlRef>
        <urlRef>http://www.nejm.org/doi/full/10.1056/NEJM198109103051106</urlRef>
        <urlRef>http://www.regulations.gov</urlRef>
        <urlRef>http://www.sciencedirect.com/science/article/pii/S096483050500137X</urlRef>
        <urlRef>http://www.thelancet.com/pdfs/journals/lancet/PIIS0140-6736</urlRef>
        <urlRef>http://www.thelancet.com/pdfs/journals/laninf/PIIS1473-3099</urlRef>
        <urlRef>https://books.google.com/books?id=3f-kPJ17_TYC&amp;printsec=frontcover&amp;dq=Disinfection,+Sterilization,+and+Preservation&amp;hl=en&amp;sa=X&amp;ved=0ahUKEwiNxurX6JHOAhWTix4KHVcKDKcQ6AEIHjAA#v=onepage&amp;q=Disinfection%2C%20Sterilization%2C%20and%20Preservation&amp;f=false</urlRef>
        <urlRef>https://books.google.com/books?id=kia7bq8EM9IC&amp;pg=PA341&amp;lpg=PA341&amp;dq=Barabas</urlRef>
        <urlRef>https://www.astm.org/</urlRef>
        <urlRef>https://www.federalregister.gov</urlRef>
        <urlRef>https://www.federalregister.gov/agencies/library-of-congress</urlRef>
        <urlRef>https://www.regulations.gov/document?D=FDA-1980-N-0006-0031</urlRef>
        <urlRef>https://www.regulations.gov/document?D=FDA-1996-P-0205-0001</urlRef>
    </extension>
    <relatedItem type="host" ID="P0b002ee1985eda74" xlink:href="https://www.govinfo.gov/metadata/pkg/FR-2016-09-06/mods.xml">
        <titleInfo>
            <title>Federal Register</title>
            <partNumber>Vol. 81, no. 172</partNumber>
        </titleInfo>
        <originInfo>
            <publisher>Office of the Federal Register, National Archives and Records Administration</publisher>
            <dateIssued encoding="w3cdtf">2016-09-06</dateIssued>
            <issuance>continuing</issuance>
            <frequency>daily</frequency>
        </originInfo>
        <physicalDescription>
            <note type="source content type">deposited</note>
            <digitalOrigin>born digital</digitalOrigin>
            <extent>492 p.</extent>
        </physicalDescription>
        <tableOfContents xlink:href="https://www.govinfo.gov/app/frtoc/2016-09-06">    
		  Table of Contents: 
		</tableOfContents>
        <classification authority="sudocs">AE 2.7:</classification>
        <classification authority="sudocs">GS 4.107:</classification>
        <classification authority="sudocs">AE 2.106:</classification>
        <classification authority="lcc">KF70.A2</classification>
        <identifier type="uri">https://www.govinfo.gov/app/details/FR-2016-09-06</identifier>
        <identifier type="local">P0b002ee1985eda74</identifier>
        <identifier type="issn">0097-6326</identifier>
        <identifier type="issn">0042-1219</identifier>
        <identifier type="issn">0364-1406</identifier>
        <identifier type="stock number">769-004-00000-9</identifier>
        <identifier type="ILS system id">000582072</identifier>
        <identifier type="former identifier">f:fr06se16</identifier>
        <location>
            <url displayLabel="Content Detail" access="object in context">https://www.govinfo.gov/app/details/FR-2016-09-06</url>
            <url displayLabel="PDF rendition" access="raw object">https://www.govinfo.gov/content/pkg/FR-2016-09-06/pdf/FR-2016-09-06.pdf</url>
            <url displayLabel="XML rendition" access="raw object">https://www.govinfo.gov/content/pkg/FR-2016-09-06/xml/FR-2016-09-06.xml</url>
        </location>
        <accessCondition type="GPO scope determination">fdlp</accessCondition>
        <part type="issue">
            <extent unit="pages">
                <start>61099</start>
                <end>61582</end>
            </extent>
        </part>
        <recordInfo>
            <recordContentSource authority="marcorg">DGPO</recordContentSource>
            <recordCreationDate encoding="w3cdtf">2018-02-09</recordCreationDate>
            <recordChangeDate encoding="w3cdtf">2024-06-01</recordChangeDate>
            <recordIdentifier source="DGPO">FR-2016-09-06</recordIdentifier>
            <recordOrigin>machine generated</recordOrigin>
            <languageOfCataloging>
                <languageTerm type="code" authority="iso639-2b">eng</languageTerm>
            </languageOfCataloging>
        </recordInfo>
        <extension>
            <docClass>FR</docClass>
            <accessId>FR-2016-09-06</accessId>
            <volume>81</volume>
            <issue>172</issue>
        </extension>
    </relatedItem>
</mods>
